1. Home
  2. SGHT vs PKE Comparison

SGHT vs PKE Comparison

Compare SGHT & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • PKE
  • Stock Information
  • Founded
  • SGHT 2011
  • PKE 1954
  • Country
  • SGHT United States
  • PKE United States
  • Employees
  • SGHT 216
  • PKE N/A
  • Industry
  • SGHT Medical Specialities
  • PKE Military/Government/Technical
  • Sector
  • SGHT Health Care
  • PKE Industrials
  • Exchange
  • SGHT Nasdaq
  • PKE Nasdaq
  • Market Cap
  • SGHT 179.7M
  • PKE 260.2M
  • IPO Year
  • SGHT 2021
  • PKE N/A
  • Fundamental
  • Price
  • SGHT $3.64
  • PKE $15.96
  • Analyst Decision
  • SGHT Buy
  • PKE
  • Analyst Count
  • SGHT 8
  • PKE 0
  • Target Price
  • SGHT $4.01
  • PKE N/A
  • AVG Volume (30 Days)
  • SGHT 164.1K
  • PKE 67.0K
  • Earning Date
  • SGHT 07-31-2025
  • PKE 07-15-2025
  • Dividend Yield
  • SGHT N/A
  • PKE 3.14%
  • EPS Growth
  • SGHT N/A
  • PKE N/A
  • EPS
  • SGHT N/A
  • PKE 0.29
  • Revenue
  • SGHT $78,109,000.00
  • PKE $62,026,000.00
  • Revenue This Year
  • SGHT N/A
  • PKE N/A
  • Revenue Next Year
  • SGHT $11.60
  • PKE N/A
  • P/E Ratio
  • SGHT N/A
  • PKE $52.72
  • Revenue Growth
  • SGHT N/A
  • PKE 10.75
  • 52 Week Low
  • SGHT $2.03
  • PKE $11.96
  • 52 Week High
  • SGHT $8.45
  • PKE $15.94
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 38.36
  • PKE 72.59
  • Support Level
  • SGHT $3.37
  • PKE $15.00
  • Resistance Level
  • SGHT $3.60
  • PKE $15.58
  • Average True Range (ATR)
  • SGHT 0.23
  • PKE 0.42
  • MACD
  • SGHT -0.12
  • PKE 0.12
  • Stochastic Oscillator
  • SGHT 8.21
  • PKE 100.00

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About PKE Park Aerospace Corp.

Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.

Share on Social Networks: